Drugs Approved for Multiple Myeloma and Other Plasma Cell Neoplasms

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for multiple myeloma and other plasma cell neoplasms. The list includes generic names, brand names, and common drug combinations, which are shown in capital letters. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in multiple myeloma and other plasma cell neoplasms that are not listed here.

Bortezomib
Carfilzomib
Clafen (Cyclophosphamide)
Cyclophosphamide
Cytoxan (Cyclophosphamide)
Doxil (Doxorubicin Hydrochloride Liposome)
Doxorubicin Hydrochloride Liposome
Dox-SL (Doxorubicin Hydrochloride Liposome)
Evacet (Doxorubicin Hydrochloride Liposome)
Kyprolis (Carfilzomib)
Lenalidomide
LipoDox (Doxorubicin Hydrochloride Liposome)
Mozobil (Plerixafor)
Neosar (Cyclophosphamide)
Plerixafor
Pomalidomide (Pomalyst)
Pomalyst
Revlimid (Lenalidomide)
Synovir (Thalidomide)
Thalidomide
Thalomid (Thalidomide)
Velcade (Bortezomib)
Zoledronic Acid
Zometa (Zoledronic Acid)